Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$753M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$711M |
| 3 |
Humana
HUM
|
+$617M |
| 4 |
NextEra Energy
NEE
|
+$610M |
| 5 |
British American Tobacco
BTI
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.32B |
| 2 |
STJ
St Jude Medical
STJ
|
+$690M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$629M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$609M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$603M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.39% |
| 2 | Technology | 9.09% |
| 3 | Healthcare | 7.39% |
| 4 | Energy | 7.04% |
| 5 | Consumer Discretionary | 6.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHK
3801
PUT
DELISTED
Chesapeake Energy Corporation
CHK
| $1.78M | ﹤0.01% |
1,496
-6,478
| -81% | -$7.87M |
|
3802
CALL
Universal Display
OLED
$3.68B
| $1.77M | ﹤0.01% |
20,600
-8,400
| -29% | -$605K |
|
3803
Stantec
STN
$8.04B
| $1.77M | ﹤0.01% |
68,507
+13,489
| +25% | +$354K |
|
|
AREX
3804
DELISTED
Approach Resources Inc.
AREX
| $1.77M | ﹤0.01% |
706,338
+577,368
| +448% | +$1.67M |
|
|
ATIS
3805
DELISTED
Attis Industries Inc. Common Stock
ATIS
| $1.77M | ﹤0.01% |
+56,928
| New | +$1.36M |
|
3806
PUT
Huntington Bancshares
HBAN
$34.4B
| $1.77M | ﹤0.01% |
132,200
-1,392
| -1% | -$19K |
|
|
LDL
3807
DELISTED
Lydall, Inc.
LDL
| $1.77M | ﹤0.01% |
32,936
-16,656
| -34% | -$945K |
|
3808
PUT
Pacira BioSciences
PCRX
$1.04B
| $1.76M | ﹤0.01% |
38,700
-15,100
| -28% | -$653K |
|
|
XENT
3809
DELISTED
Intersect ENT, Inc
XENT
| $1.76M | ﹤0.01% |
102,883
-11,241
| -10% | -$157K |
|
3810
PUT
Kilroy Realty
KRC
$4.52B
| $1.76M | ﹤0.01% |
+24,400
| New | +$1.81M |
|
|
KEYW
3811
DELISTED
The KEYW Holding Corporation
KEYW
| $1.76M | ﹤0.01% |
186,248
+154,714
| +491% | +$1.6M |
|
3812
PUT
Prothena Corp
PRTA
$425M
| $1.76M | ﹤0.01% |
31,500
+25,900
| +463% | +$1.36M |
|
|
CACB
3813
DELISTED
Cascade Bancorp
CACB
| $1.76M | ﹤0.01% |
227,897
-5,062
| -2% | -$40.2K |
|
3814
PUT
BioMarin Pharmaceuticals
BMRN
$11.6B
| $1.76M | ﹤0.01% |
+20,000
| New | +$1.78M |
|
3815
PUT
Alaska Air
ALK
$5.29B
| $1.75M | ﹤0.01% |
19,000
-3,000
| -14% | -$284K |
|
|
PRFT
3816
DELISTED
Perficient Inc
PRFT
| $1.75M | ﹤0.01% |
100,872
+8,934
| +10% | +$159K |
|
|
FLXN
3817
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $1.75M | ﹤0.01% |
65,136
+31,817
| +95% | +$650K |
|
3818
PUT
Marvell Technology
MRVL
$168B
| $1.75M | ﹤0.01% |
114,700
+63,300
| +123% | +$975K |
|
3819
ASE Group
ASX
$77.3B
| $1.75M | ﹤0.01% |
269,794
+237,127
| +726% | +$1.41M |
|
3820
PUT
W.W. Grainger
GWW
$65.3B
| $1.75M | ﹤0.01% |
7,500
-3,200
| -30% | -$788K |
|
3821
TFS Financial
TFSL
$5.16B
| $1.75M | ﹤0.01% |
105,051
-103,500
| -50% | -$1.81M |
|
3822
PUT
Mohawk Industries
MHK
$7.5B
| $1.74M | ﹤0.01% |
7,600
-7,400
| -49% | -$1.63M |
|
3823
PUT
ProShares UltraShort Bloomberg Crude Oil
SCO
$671M
| $1.74M | ﹤0.01% |
596
-1,432
| -71% | -$3.98M |
|
3824
First Majestic Silver
AG
$7.41B
| $1.74M | ﹤0.01% |
214,439
-65,380
| -23% | -$583K |
|
3825
CALL
Hecla Mining
HL
$9.47B
| $1.74M | ﹤0.01% |
329,100
-530,500
| -62% | -$3.06M |
|
Similar funds
Goldman Sachs's Q1 2017 Portfolio in Review
As of Q1 2017, Goldman Sachs held 7,322 positions worth $369B, up 4.2% from $354B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Goldman Sachs's Q1 2017 filing shows 455 new, 2,594 increased, 3,387 reduced and 597 closed positions. Its largest new stake was Deutsche Bank Aktiengesellschaft: 36,861,723 shares worth $87M. The largest sale was NVIDIA, an estimated $1.32B.
By sector, the portfolio is most concentrated in Financials at 9.4% of assets, down from 9.9% a quarter earlier, followed by Technology and Healthcare.
- Goldman Sachs's largest Q1 2017 buy was Deutsche Bank Aktiengesellschaft: 36,861,723 shares worth $87M.
- Goldman Sachs added most to Intuitive Surgical in Q1 2017, an estimated $753M increase.
- Goldman Sachs's biggest Q1 2017 reduction was NVIDIA, cutting an estimated $1.32B.
- Goldman Sachs fully exited St Jude Medical in Q1 2017, selling an estimated $690M.
- Goldman Sachs's ten largest holdings make up 16% of its $369B portfolio in Q1 2017.
- Goldman Sachs opened 455 new positions and closed 597 in Q1 2017.
- Goldman Sachs's portfolio value rose 4.2% quarter-over-quarter to $369B.
Based on Goldman Sachs's 13F filing for Q1 2017, filed 15 May 2017.